Navigating Insurance Hurdles and Policy Shortfalls in Breast Cancer Care: Anasuya Gunturi, MD, PhD
Breast Cancer Treatment Transformed With HER2 Identification: Michael Hassett, MD, MPH
Shaping the Future of Breast Cancer Care With Oral SERDs, Genomic Testing, and ctDNA: Rebecca Chacko, MD
Streamlining Breast Cancer Therapy Access for Better Patient Outcomes: Rebecca Chacko, MD
Ovarian, Breast Cancer Disparities Highlight Need for Better Screening: CK Wang, MD
Investigators Advocate for Ongoing Comparison of Cancer Outcomes Among MA, FFS Beneficiaries
No Significant Differences Found in Breast Cancer Treatment Between MA, FFS Beneficiaries: Galen Shearn-Nance, BS
Mixed Outcomes Persist Between MA, FFS Beneficiaries: Johnie Rose, MD, PhD
Collaborative Approaches Provide Comprehensive Support in Cancer Care
TROPION-Breast01: The Evolving Role of TROP2-Directed ADCs in Breast Cancer
Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
The Disproportionate Impact of the Pandemic on Health Care Disparities and Cancer
Living Life With Metastatic Breast Cancer From a Male Perspective
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
TILs: A Decade of Research Shapes Global Standards for Breast Cancer
Race and Immune Microenvironment Impacts on Breast Cancer Outcomes